Category: Non-NIH

A goal of the Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is to support the discovery and development of interventions to prevent or delay the development of T1D. To address this, the Helmsley T1D Program is pleased to announce a new funding opportunity:  

• New efforts to understand relationships between the prenatal development period and initiation of islet autoimmunity.

Learn More HERE

Posted: February 1, 2022
Concept notes due: March 15, 2022 
Full grant proposal due: June 1, 2022 
Start date: November 1, 2022 

A goal of the Helmsley Charitable Trust’s (Helmsley) Type 1 Diabetes (T1D) Program is to support the discovery and development of interventions to prevent or delay the development of T1D. To address this, the Helmsley T1D Program is pleased to announce a new funding opportunity: 

• New studies into understanding and therapeutically emulating examples where individuals are naturally protected from developing T1D.

Learn More HERE

Posted: February 1, 2022
Concept notes due: March 15, 2022 
Full grant proposal due: June 1, 2022 
Start date: November 1, 2022